Walgreens Weight Loss Clinics Review
Walgreens Boots Alliance (NASDAQ: WBA) launched in-store weight loss clinics on February 26, 2026, entering the GLP-1 prescribing space with a pay-per-visit model that undercuts virtually every competitor on visit cost. At $49 per consultation — no subscription, no membership — Walgreens is targeting patients who already have insurance coverage for brand-name GLP-1 medications and want a low-friction, in-person path to a prescription.
Quick Facts
| Starting Price | Contact provider |
| Medications | 2 peptides |
| Consultation | In-Person |
| Shipping | 3-5 business days |
| Lab Testing | Not included |
| Prescriber | licensed nurse practitioners and physician assistants at existing Walgreens locations, with the obvious advantage of on-site pharmacy fulfillment. |
Walgreens Weight Loss Clinics offers 2 peptides for GLP-1 therapy. Walgreens Boots Alliance (NASDAQ: WBA) launched in-store weight loss clinics on February 26, 2026, entering the GLP-1 prescribing space with a pay-per-visit model that undercuts virtually every competitor on visit cost. At $49 per consultation — no subscription, no membership — Walgreens is targeting patients who already have insurance coverage for brand-name GLP-1 medications and want a low-friction, in-person path to a prescription.
Pros & Cons
What We Like
- $49 per visit is the lowest consultation cost in the GLP-1 prescribing market
- No subscription or membership commitment
- In-person consultations with licensed clinicians
- On-site Walgreens pharmacy means prescriptions can be filled immediately
- Insurance-friendly model designed around patients with existing GLP-1 coverage
- Brand-name medications only
Watch Out For
- Recently launched (February 26, 2026); currently in approximately 28 states and expanding
- No virtual or telehealth option
- No compounded GLP-1 medications
- No behavioral support, coaching, or dietitian access
- No clinical specialization in obesity medicine
- Lab work not included and requires external referral
Pricing Breakdown
Pricing not yet verified for Walgreens Weight Loss Clinics. Visit their site for current pricing →
Medications Offered
2 peptides available through Walgreens Weight Loss Clinics.
Semaglutide
weight-loss · Subcutaneous injection (weekly)
A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.
Tirzepatide
weight-loss · Subcutaneous injection (weekly)
A dual GIP/GLP-1 receptor agonist for weight management and type 2 diabetes. Clinical trials show significant weight reduction, often exceeding semaglutide results.
Considering Walgreens Weight Loss Clinics?
Request a free, no-obligation consultation. We'll share your details with Walgreens Weight Loss Clinicsand they'll reach out within 1–2 business days.
Patient Reviews
No patient reviews on Telehealth Ally yet. Be the first to review Walgreens Weight Loss Clinics
Used Walgreens Weight Loss Clinics? Help others decide.
Leave your email and we'll send you a short, 3-minute review form. Your honest experience helps the next patient make a better choice.
We'll only email you once about this review. No spam. Write a review now
How Walgreens Weight Loss Clinics Compares
See how Walgreens Weight Loss Clinics stacks up against other GLP-1 providers.
Provider Comparisons
Medication Comparisons
Ready to explore Walgreens Weight Loss Clinics?
Based on our independent review, Walgreens Weight Loss Clinics offers 2 peptides for GLP-1 therapy. Request a free consultation or visit their site to get started.
Telehealth Ally may receive compensation when you request a consultation. This does not affect our rankings or reviews.
Get weekly GLP-1 pricing updates
We track prices so you don't have to.
No spam. Unsubscribe anytime.
How We Review Providers
Our editorial team independently evaluates every telehealth provider based on pricing transparency, medication availability, clinical protocols, and patient experience. We verify pricing data weekly and update reviews when providers change their offerings. Revenue never influences our rankings or recommendations.
Read our editorial standards →